Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Eupraxia Pharmaceuticals Inc | EPRX | Toronto | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
6.98 | 6.95 | 7.14 | 6.95 | 7.00 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
37 | 11,792 | - | 0.89 - 7.50 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
15:59:59 | 100 | $ 6.95 | CAD |
Eupraxia Pharmaceuticals Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 151.15M | 20.87M | 20.87M | $ - | $ 0.00 | -0.44 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
126.15k | $ - | - | 655.00k | 10.30% |
Eupraxia Pharmaceuticals News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EPRX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 7.00 | 7.25 | 6.84 | 6.99 | 19,389 | -0.05 | -0.71% |
1 Month | 7.10 | 7.35 | 6.63 | 7.06 | 20,101 | -0.15 | -2.11% |
3 Months | 4.01 | 7.50 | 3.96 | 6.30 | 16,517 | 2.94 | 73.32% |
6 Months | 3.72 | 7.50 | 3.57 | 4.82 | 23,711 | 3.23 | 86.83% |
1 Year | 1.38 | 7.50 | 0.89 | 3.36 | 25,486 | 5.57 | 403.62% |
3 Years | 7.75 | 7.75 | 0.80 | 3.13 | 21,385 | -0.80 | -10.32% |
5 Years | 7.75 | 7.75 | 0.80 | 3.13 | 21,385 | -0.80 | -10.32% |
Eupraxia Pharmaceuticals Description
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. |